We are live on ! Find out more
SNTI icon

Senti Biosciences Holdings
SNTI

22 hedge funds and large institutions have $44.4M invested in Senti Biosciences Holdings in 2022 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4.45% less ownership

Funds ownership: 7.69% → 3.24% (-4.4%)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

51% less funds holding

Funds holding: 45 → 22 (-23)

68% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 34

75% less capital invested

Capital invested by funds: $180M → $44.4M (-$136M)

Holders
22
Holders Change
-23
Holders Change %
-51.11%
% of All Funds
0.37%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
4
Reduced
6
Closed
34
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
+$35.6M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$28M
3
CCM
CAAS Capital Management
New York
+$6.08M
4
IC
Intel Corp
California
+$4.78M
5
AG
Artal Group
Luxembourg
+$4.46M

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$19.7M
2
SC
Sculptor Capital
New York
-$15.2M
3
Morgan Stanley
Morgan Stanley
New York
-$11.5M
4
Marshall Wace
Marshall Wace
United Kingdom
-$9.34M
5
FTCM
First Trust Capital Management
Illinois
-$7.68M
Name Holding Trade Value Shares
Change 		Change in
Stake
JP Morgan Chase
26
JP Morgan Chase
New York
– -$5.45M -55,198 Closed
WCMNY
27
Westchester Capital Management (New York)
New York
– -$5.4M -54,702 Closed
APM
28
Avidity Partners Management
Texas
– -$4.93M -50,000 Closed
TCA
29
Taconic Capital Advisors
New York
– -$4.94M -50,000 Closed
KC
30
Kryger Capital
United Kingdom
– -$4.61M -46,690 Closed
SRF
31
Silver Rock Financial
California
– -$3.84M -38,896 Closed
CIM
32
Cowen Investment Management
New York
– -$3.46M -35,000 Closed
GL
33
Governors Lane
New York
– -$3.46M -35,000 Closed
Jane Street
34
Jane Street
New York
– -$2.96M -30,009 Closed
CCM
35
Cinctive Capital Management
New York
– -$2.96M -30,000 Closed
CH
36
CVI Holdings
Delaware
– -$2.48M -25,153 Closed
IPCP
37
Iron Park Capital Partners
New York
– -$2.23M -22,554 Closed
AA
38
AQR Arbitrage
Connecticut
– -$2.15M -21,751 Closed
AIMCA
39
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$1.98M -20,000 Closed
TCM
40
Tenor Capital Management
New York
– -$1.97M -19,995 Closed
D.E. Shaw & Co
41
D.E. Shaw & Co
New York
– -$1.48M -14,942 Closed
MTCM
42
Mint Tower Capital Management
Netherlands
– -$987K -10,000 Closed
SCM
43
Segantii Capital Management
Hong Kong
– -$988K -10,000 Closed
Goldman Sachs
44
Goldman Sachs
New York
– -$814K -8,250 Closed
DCM
45
Dupont Capital Management
Delaware
– -$691K -7,000 Closed
SSA
46
Schonfeld Strategic Advisors
New York
– -$596K -6,035 Closed
RL
47
RPO LLC
Connecticut
– -$480K -4,871 Closed
CAC
48
Cowen and Company
New York
– -$466K -4,720 Closed
HSBC Holdings
49
HSBC Holdings
United Kingdom
– -$436K -4,426 Closed
BFM
50
Boothbay Fund Management
New York
– -$291K -2,950 Closed
1
2
3

SNTI Hedge Fund Activity: Q2 2022 in Review

22 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Senti Biosciences Holdings (SNTI) for Q2 2022, worth a combined $44.4M — down 75% from $180M a quarter earlier.

Sellers outnumbered buyers: 34 funds closed out of SNTI and 11 opened new positions — a net loss of 23 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was NEA Management Company, opening a new position worth an estimated $35.6M. The largest seller was Woodline Partners, exiting entirely with an estimated $19.7M sold.

  • 22 institutional investors held Senti Biosciences Holdings (SNTI) as of Q2 2022, down from 45 in Q1 2022.
  • Funds reported $44.4M of Senti Biosciences Holdings stock for Q2 2022, down 75% quarter-over-quarter.
  • 11 funds opened new Senti Biosciences Holdings positions in Q2 2022 and 34 closed out, a net change of -23 holders.
  • The largest Senti Biosciences Holdings buyer in Q2 2022 was NEA Management Company, an estimated $35.6M added.
  • The largest Senti Biosciences Holdings seller in Q2 2022 was Woodline Partners, an estimated $19.7M sold.

Based on aggregated 13F filings for Q2 2022.